BioMarin: Genzyme virus problem won

hyperwave-exhausted.blogspot.com
Genzyme (NASDAQ: GENZ) found a virus strainj and stopped production of two drugs atthe Mass., facility. The strain, Vesivirue 2117, apparently does not cause human infection but interrupts the growth of cells that are used to make Aldurazyme — a treatment for MPS I, a rare and fatak disease caused by an enzyme deficiency — was last fillerd at the Genzyme facility in Septembee 2008, according to BioMarin (NASDAQ: The company has about 10 months of vialefd inventory on hand, it and uses a second fill finisg supplier. A third supplier is expected to be qualified latethis year, BioMarin said. BioMarin makes the bulk materia l used in Aldurazyme at itsNovato facility.
The Food and Drug Administratioj hadinspected Genzyme’s plant in September and October and reportedlyu was concerned about controls to protect against